This key area is based on network functioning of components distributed between several partners:

  • Rodent imaging: CIMA (CRCINA, teaching hospital of Nantes)
  • Imaging of large animals: CEMA (Oniris National veterinary, food processing and food school)
  • Clinical trials: Department of Nuclear Medicine of the teaching hospital of Nantes and the ICO

Arronax Nantes can thus provide different skills and facilities around pre-clinical imagery of both rodents and medium-sized animals.

Our strengths

  • First-rate multidisciplinary scientific expertise (biologists, immunologists, radiopharmacists, veterinary surgeons, nuclear doctors, medical physicists)
  • Translational research: from mice to men
  • An extended collaboration network (IRON laboratory of excellence, IGO laboratory of excellence, SIRIC ILIAD, etc.)
  • Experience in public/private collaborative projects
  • Experience and methodology for clinical trials in nuclear medicine

Our offer

  • Collaborative R&D projects
  • Imaging services
  • Assistance and provision of facilities for trained users, subject to reservation and invoicing by the hour
  • Clinical trials (promotion, investigation)
  • Contractualization of partnerships with scientific, academic and industrial teams.
  • Confidentiality guaranteed, follow-up and traceability, quality assurance.

our publications

  • Validation of the ΔSUVmax for interim PET interpretation in diffuse large B-cell lymphoma on the basis of the GAINED clinical study. Itti E, Blanc-Durand P, Berriolo-Riedinger A, Kanoun S, Kraeber-Bodéré F, Meignan M, Gat E, Le Gouill S, Casasnovas RO, Bodet-Milin C. J Nucl Med. 2023, 64: 1706-1711. https://doi.org/10.2967/jnumed.123.265871

  • Multiple myeloma mimicking metastatic skull base paraganglioma in [68 Ga]Ga-DOTATOC-PET/CT and 2-[18F]FDG-PET/CT imaging. Jamet B, Bodet-Milin C, Moreau P, Touzeau C, Kraeber-Bodéré F. Eur J Nucl Med Mol Imaging. 2023, 3792-3793. https://doi.org/10.1007/s00259-023-06322-0

  • New developments in myeloma treatment and response assessment. Kraeber-Bodéré F, Jamet B, Bezzi D, Zamagni E, Moreau P, Nanni C. J Nucl Med. 2023, 64: 1331-1343. https://doi.org/10.2967/jnumed.122.264972

our news